COMP <GO>
IQV vs MRK // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
IQVIA Holdings Inc. (NYSE) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: IQV 3
— MRK 12
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MRK
LAST: $267.33 (-2.81%) • MKT CAP: $45.33B
options-implied-move
7.40%
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
options-implied-move
6.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IQV VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IQV | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 74.80% | -33.80 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.40% | 20.70% | -11.30 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 20.4x | 15.3x | +5.10 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.24% | 3.42% | +0.82 | IQV | /fcf-yield <GO> |
| Operating Margin | 13.40% | 34.30% | -20.90 | MRK | /operating-margins <GO> |
| Net Profit Margin | 8.30% | 28.10% | -19.80 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 5.90% | 1.30% | +4.60 | IQV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.22 | 5.19 | -2.97 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 7/9 | -1.00 | MRK | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 7.40% | 6.60% | +0.80 | MRK | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.0 | 56.9 | -7.86 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.16 | 0.92 | +0.24 | IQV | /macro-sensitivity <GO> |
| Forward P/E Multiple | 31.0x | 18.4x | +12.60 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $45.33B | $361.02B | -$315.69B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IQV REV | MRK REV | IQV GROSS % | MRK GROSS % | IQV FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $16.31B | $65.01B | 44.0% | 74.8% | $1.92B | $12.36B |
| FY 2024 | $15.40B | $64.17B | 44.0% | 76.3% | $2.02B | $18.10B |
| FY 2023 | $14.98B | $60.12B | 44.0% | 44.0% | $1.47B | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IQV // BETA 1.16
MRK // BETA 0.92